NCT02424513View on ClinicalTrials.gov

A Study of Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate Cancer

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Prostate Cancer
Interventions
RADIATION

[89Zr]Df-IAB2M

A single intravenous infusion of 2.5 mCi of \[89Zr\]Df-IAB2M in a mass dose of 10 mg.

Trial Locations (1)

63110

Washington University, St Louis

Sponsors

Lead Sponsor

ImaginAb, Inc.
All Listed Sponsors
lead

ImaginAb, Inc.

INDUSTRY